Berx G - Search Results

1

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.

2

Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells.

Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM. Vermeulen SJ, et al. Among authors: berx gj. Cancer Res. 1995 Oct 15;55(20):4722-8. Cancer Res. 1995. PMID: 7553655

3

Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1).

Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. Berx G, et al. Genomics. 1995 Mar 20;26(2):281-9. doi: 10.1016/0888-7543(95)80212-5. Genomics. 1995. PMID: 7601454

4

Isolation and characterization of a human pseudogene (CTNNAP1) for alpha E-catenin (CTNNA1): assignment of the pseudogene to 5q22 and the alpha E-catenin gene to 5q31.

Nollet F, van Hengel J, Berx G, Molemans F, van Roy F. Nollet F, et al. Among authors: berx g. Genomics. 1995 Mar 20;26(2):410-3. doi: 10.1016/0888-7543(95)80231-a. Genomics. 1995. PMID: 7601473

5

Assignment of the human beta-catenin gene (CTNNB1) to 3p22-->p21.3 by fluorescence in situ hybridization.

van Hengel J, Nollet F, Berx G, van Roy N, Speleman F, van Roy F. van Hengel J, et al. Among authors: berx g. Cytogenet Cell Genet. 1995;70(1-2):68-70. doi: 10.1159/000133994. Cytogenet Cell Genet. 1995. PMID: 7736793

6

Cadherin/catenin complex: a target for antiinvasive therapy?

Mareel M, Berx G, Van Roy F, Bracke M. Mareel M, et al. Among authors: berx g. J Cell Biochem. 1996 Jun 15;61(4):524-30. doi: 10.1002/(SICI)1097-4644(19960616)61:4%3C524::AID-JCB5%3E3.0.CO;2-Q. J Cell Biochem. 1996. PMID: 8806075 Review.

7

Genomic organization of the human beta-catenin gene (CTNNB1).

Nollet F, Berx G, Molemans F, van Roy F. Nollet F, et al. Among authors: berx g. Genomics. 1996 Mar 15;32(3):413-24. doi: 10.1006/geno.1996.0136. Genomics. 1996. PMID: 8838805

8

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. Berx G, et al. Oncogene. 1996 Nov 7;13(9):1919-25. Oncogene. 1996. PMID: 8934538

9

E-cadherin gene alterations are rare events in thyroid tumors.

Soares P, Berx G, van Roy F, Sobrinho-Simões M. Soares P, et al. Among authors: berx g. Int J Cancer. 1997 Jan 6;70(1):32-8. doi: 10.1002/(sici)1097-0215(19970106)70:1<32::aid-ijc5>3.0.co;2-7. Int J Cancer. 1997. PMID: 8985087

10

An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene.

Berx G, Nollet F, Strumane K, van Roy F. Berx G, et al. Hum Mutat. 1997;9(6):567-74. doi: 10.1002/(SICI)1098-1004(1997)9:6<567::AID-HUMU11>3.0.CO;2-0. Hum Mutat. 1997. PMID: 9195232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters